Minor
TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis
Trial sites reduced: 6 → 1 locations
Also in this update: Interventions modified; Trial arms changed: 2 → 4
Toll Biotech Co. Ltd. (Beijing)Phase 2 NCT07408024 Registry history of NCT07408024 on ClinicalTrials.gov (opens the registry)